Signum Surgical

Signum Surgical

Treating Anal Fistulas at the Source.

More about Signum Surgical
Edit

Signum Surgical is the medical technology company developing innovative solutions to treat colorectal diseases.

About the BioHealx Technology

The Signum Surgical BioHealx®Anal Fistula Device is designed to close the fistula tract by tissue apposition to deliver primary healing. The device contains a single synthetic absorbable implant in the shape of a helical coil, preloaded into a special purpose single use delivery system. The device is designed for introduction and implant delivery under direct visualization. The BioHealx device has received FDA De Novo 510(k) Clearance.

About Anal Fistulas

Anal fistula disease occurs more often in men, ages 18-50. Fistulas have a complicated pathogenesis resulting in poor quality of life due to frequent recurrence, fecal incontinence, abscess, odor, and pain. Fistulas were first described by Hippocrates over 2,500 years ago, yet surgical procedures are often associated with suboptimal treatment results including incontinence and the need for repeat procedures due to recurrence.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo